Robert Welsh

Has grant

University of Alberta

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

COMPLETE Trial: Complete revascularization versus optimal medical therapy to treat residual multi-vessel disease in patients with ST-segment elevation myocardial infarction.

Open Date: 2014-07-01

Close Date: 2019-06-30

Grant: Close

A randomized trial of ThrOmbectomy vs. PCI Alone for STEMI (TOTAL trial)

Open Date: 2012-04-01

Close Date: 2015-09-30

Grant: Close

Video KT of Acute Coronary Syndrome (Prodromal Symptoms and WEST Study)

Open Date: 2011-02-01

Close Date: 2012-01-31

Grant: Close

Annual Cardiovascular Conference Lake Louise

Open Date: 2010-01-01

Close Date: 2010-12-31

Grant: Close

Tracking gender differences in acute coronary syndromes: At the first point of care and beyond

Open Date: 2008-10-01

Close Date: 2011-09-30

Articles (23)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Scott Berkowitz

Professor of Medicine

UNITED STATES

View details

Anamaria Savu

University of Alberta

CANADA

View details

Peter Sinnaeve

Professor

University Hospitals Leuven

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Welsh

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (23)

Review of Transcatheter Aortic Valve Insertion (TAVI) Clinician Opinions on the Canadian Cardiovascular Society Post-TAVI Driving Guidelines

Dual Pathway Inhibition in Patients with Atherosclerosis with or without Heart Failure: Insights from the XATOA Registry

Is there a role for pre-hospital administration of potent antiplatelet therapy in ST-segment elevation myocardial infarction?

Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA Registry

Applicability and impact of the COMPASS trial in a Canadian population of patients with atherosclerotic disease

Outcomes of management strategies in patients with prior coronary artery bypass grafting presenting with an acute coronary syndrome

Response by Van de Werf et al to Letter Regarding Article, “STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment–Elevation Myocardial Infarction: A Randomized, Open-Label Trial”

Reperfusion in Patients With ST-Segment–Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport Times

Antiplatelet Pretreatment Before Angiography With Anticipated or Planned Percutaneous Coronary Intervention in Stable Ischemic Heart Disease

Identifying the Highest Risk Vascular Patients: insights from the XATOA Registry.

Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)

Prevalence of Peripheral Arterial Disease in Patients With Coronary Artery Disease After Cardiac Catheterization: A Prospective Observational Study

Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up

The Challenges of Identifying Patients With Peripheral Artery Disease Utilizing Administrative Databases

Patients acceptance and comprehension to written and verbal consent (PAC–VC)

Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry

Primary Percutaneous Coronary Intervention and Application of the Pharmacoinvasive Approach Within ST-Elevation Myocardial Infarction Care Networks

Evaluation and management of chronic kidney disease patients with stable ischemic heart disease

Long-Term Outcomes for Patients With Acute Coronary Syndrome and Nonvalvular Atrial Fibrillation

Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction

Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial

Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment–Elevation Myocardial Infarction: Insights From the COMPLETE Trial

Collaborators (3)

Scott Berkowitz

Anamaria Savu

Peter Sinnaeve

Make your next move.